Publication of Full Year Financial Results delayed | 03-May-2024 | 16:44 | RNS |
Notice of results | 29-Apr-2024 | 07:00 | RNS |
BOARD CHANGE | 23-Apr-2024 | 07:00 | RNS |
Arecor and TRx Biosciences research collaboration | 12-Mar-2024 | 08:58 | RNS |
Arecor announces launch of Ogluo® in ... | 29-Feb-2024 | 07:00 | RNS |
Year End Trading Update | 01-Feb-2024 | 07:00 | RNS |
Arecor announces update on INBRX-101 | 23-Jan-2024 | 16:58 | RNS |
Arecor granted key European patent | 18-Jan-2024 | 07:00 | RNS |
Expansion of specialty hospital collaboration | 08-Jan-2024 | 07:00 | RNS |
Appointment of SVP for Tetris Pharma Ltd | 03-Jan-2024 | 07:00 | RNS |
Agreement with global medical products company | 04-Dec-2023 | 07:00 | RNS |
Arecor Continues Collaboration with Lilly | 29-Nov-2023 | 07:00 | RNS |
Product with Arestat technology launched in Europe | 17-Nov-2023 | 07:00 | RNS |
Inhibrx milestone triggers payment to Arecor | 02-Nov-2023 | 07:00 | RNS |
Exercise of rollover options & Total Voting Rights | 01-Nov-2023 | 15:31 | RNS |
Currency | UK Pounds |
Share Price | 137.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 270.00 |
52 Week Low | 128.50 |
Volume | 17,518 |
Shares Issued | 30.63m |
Market Cap | £42.11m |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
No dividends found |
Time | Volume / Share Price |
16:23 | 1,448 @ 137.84p |
15:35 | 3,624 @ 137.84p |
15:32 | 4,349 @ 137.84p |
09:32 | 3,627 @ 137.84p |
08:47 | 3,500 @ 135.25p |
You are here: research